Search Results
Jul 16, 2026, 10:31 ET Complement 3 Glomerulopathy Market Set for Transformation: 4 Emerging Therapies Leading the Next Growth Phase | DelveInsight
IgA Nephropathy MarketIgA Nephropathy Market Insight, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding
More news about: DelveInsight Business Research, LLP
Jun 30, 2026, 09:11 ET Securden Recognized as a Leader in the Frost Radar™: Privileged Access Management, 2026
pose the greatest risk.The Frost Radar™ highlights that Securden has moved beyond a traditional vault-centric PAM model by natively integrating IGA and CIEM within an identity-centric data and analytics layer providing a solid foundation for identity security convergence."Securden's emphasis
More news about: Securden, Inc.
Jun 30, 2026, 02:03 ET Omada Agent Governance laajentaa identiteetin-hallinan tekoälyagentteihin
30. kesäkuuta 2026 /PRNewswire/ -- Omada A/S ("Omada"), tekoälypohjaisen identiteetin hallinnan ja käyttöoikeushallinnan (IGA) maailmanlaajuinen markkinajohtaja, julkisti tänään Omada Agent Governance -ratkaisun, joka on suunniteltu auttamaan organisaatioita soveltamaan tekoälyagentteihin
More news about: Omada
Jun 30, 2026, 02:03 ET Omada Agent Governance, Extends Identity Governance to AI Agents
June 30, 2026 /PRNewswire/ -- Today Omada A/S ("Omada"), a global leader in AI-powered Identity Governance and Administration (IGA), announced Omada Agent Governance, a new solution designed to help organizations bring the same governance discipline to AI agents and non-human identities
More news about: Omada
Jun 30, 2026, 02:03 ET Omada Agent Governance utökar identitetsstyrning till AI-agenter
30 juni, 2026 /PRNewswire/ -- Omada A/S ("Omada"), en global ledare inom AI-driven Identity Governance and Administration (IGA), lanserade i dag Omada Agent Governance, en ny lösning som hjälper organisationer att tillämpa samma styrningsdisciplin på AI-agenter och icke-mänskliga
More news about: Omada
Jun 30, 2026, 02:03 ET Omada Agent Governance breidt Identity Governance uit naar AI-agenten
30 juni 2026 /PRNewswire/ -- Omada A/S ("Omada"), wereldwijd leider in AI-gedreven Identity Governance and Administration (IGA), kondigt vandaag Omada Agent Governance aan. Deze nieuwe oplossing stelt organisaties in staat om dezelfde governanceprincipes die zij toepassen
More news about: Omada
Jun 30, 2026, 02:03 ET Omada Agent Governance utvider Identity Governance til AI-agenter
30. juni 2026 /PRNewswire/ -- I dag kunngjorde Omada A/S («Omada»), en global leder innen AI-drevet Identity Governance and Administration (IGA), lanseringen av Omada Agent Governance Den nye løsningen er utviklet for å hjelpe organisasjoner med å innføre den samme styringsdisiplinen for AI-agenter
More news about: Omada
Jun 30, 2026, 02:03 ET Omada lance Agent Governance pour sécuriser les agents IA et les Identités non humaines
30 juin 2026 /PRNewswire/ -- Omada A/S (« Omada »), leader mondial dans le domaine de la gouvernance et de l'administration des identités (IGA) basées sur l'IA, a annoncé aujourd'hui le lancement d'Omada Agent Governance, une nouvelle solution conçue pour aider les entreprises à appliquer aux
More news about: Omada
Jun 30, 2026, 02:03 ET Omada Agent Governance udvider Identity Governance til AI-agenter
30. juni 2026 /PRNewswire/ -- Omada A/S ("Omada"), en global leder inden for AI-drevet Identity Governance and Administration (IGA), annoncerede for nyligt Omada Agent Governance. Den nye løsning giver virksomheder mulighed for at styre deres AI-agenters adgangsrettigheder, på samme
More news about: Omada
Jun 29, 2026, 10:31 ET Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight
IgA Nephropathy MarketIgA Nephropathy Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease,
More news about: DelveInsight Business Research, LLP
Jun 29, 2026, 08:00 ET 禮邦醫藥（09637.HK）正式在香港聯合交易所主板掛牌上市
已完成中國III期註冊臨床試驗，將於近期提交新藥上市申請，有望早日為治療高磷血症的患者提供更優的選擇。同時，我們也在全力加速後續管線臨床進程，推動前沿腎病治療方案更快惠及腎臟病患者。"關於禮邦醫藥禮邦醫藥（09637.HK）於 2018 年初在中國上海成立，是一家聚焦腎臟病及其相關慢性疾病的綜合性創新生物制藥公司，主要致力於相關創新藥物的發現、開發、生產和商業化，為全球慢性腎臟病及相關疾病患者提供更佳的臨床治療方案。禮邦醫藥已建立起豐富且均衡的腎臟病新藥產品管線，包括七款在研產品及一款已上市產品（美信羅®），適應症涵蓋高磷血症、腎性貧血、IgA 腎病、糖尿病腎病、局灶節段性腎小球硬化（FSGS）、常染色體顯性多囊腎病（ADPKD）等。公司已在江蘇揚州建成並啓用生產基地，以支持 AP301
More news about: 禮邦醫藥
Jun 29, 2026, 08:00 ET Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
differentiated dual PPAR agonist designed to delay or halt the progression of CKD across potential indications including diabetic kidney disease (DKD) and IgA nephropathy (IgAN), and has received Orphan Drug Designation (ODD) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) from the U.S. FDA. In the
More news about: Alebund Pharmaceuticals
Jun 29, 2026, 07:30 ET Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease
free T4 and free T3 in patients with Graves' hyperthyroidismImprovements in hallmark symptoms of Graves' diseasePreservation of IgG3, IgA, IgM, and IgEFavorable safety and tolerabilityBHV-1300 is the first extracellular degrader to reach a pivotal trial, opening the
More news about: Biohaven Ltd.
Jun 29, 2026, 06:59 ET Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
open-label study conducted in Japan to evaluate the efficacy and safety of oral VR-205 (targeted-release budesonide formulation) for the treatment of primary IgA nephropathy in Japanese adult patients at risk of developing end-stage renal disease. The study enrolled a total of 39 participants who were treated
More news about: Viatris Inc.
Jun 24, 2026, 03:50 ET 雲頂新耀與海南合瑞就耐賦康®相關專利達成諒解並開展商業化合作
性。耐賦康®專為IgA腎病患者研製，每顆膠囊含布地奈德4mg，通過特殊的遲釋及緩釋雙重制劑工藝，將布地奈德三層包衣微丸靶向釋放於迴腸末端的黏膜B細胞（包括派爾集合淋巴結），三層包衣微丸持續穩定釋放布地奈德，高濃度覆蓋整個靶區域，從而減少誘發IgA腎病的半乳糖缺陷的IgA1（Gd-IgA1）產生，進而干預發病機制上游階段，達到治療IgA腎病的作用。2019年6月，雲頂新耀與Calliditas Therapeutics 簽訂獨家授權許可協議，獲得在大中華地區和新加坡開發以及商業化耐賦康®的權利。該協議於2022年3月擴展，將韓國納入雲頂新
More news about: 雲頂新耀
Jun 23, 2026, 02:03 ET Omada introduceert Omada Identity Sovereign en biedt gereguleerde organisaties digitale soevereiniteit
structurele uitdaging die vraagt om een oplossing van een echte Europese IGA-leverancier. Als toonaangevende Europese aanbieder van IGA, met ruime ervaring in het ondersteunen
More news about: Omada
Jun 23, 2026, 02:03 ET Omada esittelee Omada Identity Sovereign -ratkaisun, joka tuo digitaalisen itsemääräämisoikeuden säännellyille organisaatioille
vai jäävätkö ne alttiiksi riskeille.Kyseessä on rakenteellinen ongelma, jonka vain aidosti eurooppalainen IGA-toimittaja voi ratkaista. Johtavana eurooppalaisena IGA-toimittajana, jolla on vankka kokemus säänneltyjen organisaatioiden palvelemisesta, Omada on ainutlaatuisessa asemassa auttaakseen
More news about: Omada
Jun 23, 2026, 02:03 ET Omada Introduces Omada Identity Sovereign, Bringing Digital Sovereignty for Regulated Organizations
meeting their regulatory obligations and remaining exposed.This is a structural problem, and one that only a truly European IGA vendor can resolve. As the leading European IGA vendor, with deep experience serving regulated organizations, Omada is uniquely positioned to help customers address the growing
More news about: Omada
Jun 23, 2026, 02:03 ET Omada lanserer Omada Identity Sovereign og tilbyr regulerte organisasjoner digital suverenitet
utfordring som krever en løsning fra en reell europeisk IGA-leverandør. Som Europas ledende IGA-leverandør, med omfattende erfaring fra å støtte regulerte organisasjoner, er Omada unikt
More news about: Omada
Jun 23, 2026, 02:03 ET Omada introducerar Omada Identity Sovereign, digital suveränitet för reglerade organisationer
att fortsatt vara exponerad för risker.Detta är ett strukturellt problem som endast en verkligt europeisk IGA-leverantör kan lösa. Som Europas ledande IGA-leverantör, med lång erfarenhet av att stödja reglerade organisationer, har Omada en unik position för att hjälpa kunder att möta de
More news about: Omada
Jun 23, 2026, 02:03 ET Omada lance « Omada Identity Sovereign », une solution qui garantit la souveraineté numérique des organisations réglementées
23 juin 2026 /PRNewswire/ -- Omada, premier fournisseur européen de solutions de gouvernance et d'administration des identités (IGA), a présenté aujourd'hui Omada Identity Sovereign, une nouvelle solution qui permet aux organisations de contrôler directement où et comment la gouvernance
More news about: Omada
Jun 23, 2026, 02:03 ET Omada lancerer Omada Identity Sovereign - Identitetsstyring og -administration med digital suverænitet
Danmark, 23. juni 2026 /PRNewswire/ -- Omada, Europas førende udbyder af Identity Governance and Administration (IGA), lancerer i dag Omada Identity Sovereign. Den nye løsning giver organisationer direkte kontrol over,
More news about: Omada
Jun 16, 2026, 08:00 ET COACH LAUNCHES "&COACH," A NEW GEN Z BRAND PLATFORM CO-CREATED FROM THE INSIDE OUT
platform evolves over time."Launching with voices including Charli xcx, Malala Yousafzai, Paige Bueckers, Toni Breidinger, PinkPantheress, Avantika, Iga Świątek and KiiiKiii, &Coach unfolds through social-first storytelling shaped by each participant's own perspective, voice and sense of self.At
More news about: Coach, Inc.
Jun 16, 2026, 07:00 ET DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES
Biopsy-Proven Glomerular Disease in China: A Systematic Review. Chin Med J (Engl), 131(6):731–735; and Du X, Xiao D, Ao C, Zhang Y, Xuan J. Disease Burden of IgA Nephropathy in China. ISPOR Europe 2021. (poster/presentation)
More news about: Dimerix Limited
Jun 15, 2026, 12:00 ET Lumos Launches the Identity Agent Force to Govern Access for Every Human, NHI, and AI Identity
Identity Governance (IGA) backbone, the agents go beyond point-in-time fixes. Every action can be translated into durable policy, improving security posture and compliance with
More news about: Lumos